**Background:** The intestinal microbiota plays critical roles in metabolism, nutrition, and immunity in fish. Rainbow trout are highly susceptible to bacterial cold-water disease (BCWD) caused by Flavobacterium psychrophilum, which can cause up to 90% mortality in fry and up to 20% in juveniles/adults. Florfenicol is commonly used to treat BCWD, but its effects on gut microbiota composition over time are poorly understood. This study aimed to evaluate the impact of prophylactic oral florfenicol and erythromycin treatment on intestinal microbiota composition and subsequent susceptibility to F. psychrophilum infection in rainbow trout juveniles.
**Methods:** Rainbow trout juveniles (30–40 g) were housed in 12 tanks (50 fish/tank) at 10.0 ± 1.0°C. Four groups (triplicate tanks each) were established: untreated mock-infected control (Ca), untreated infected (Cb), florfenicol-treated infected (F; 10 mg/kg/day), and erythromycin-treated infected (E; 75 mg/kg/day). Antibiotics were administered orally for 10 consecutive days. Fish were then injected intraperitoneally with F. psychrophilum FPG101 (1 × 10^8 cfu/fish) or sterile Cytophaga broth (controls). Intestinal contents were collected at days −11, 0, 12, and 24 post-infection (p.i.). The V3–V4 region of the 16S rRNA gene was sequenced using Illumina MiSeq. Splenic bacterial load was quantified using rpoC qPCR on days 3, 6, 9, and 12 p.i. Survival was monitored for 24 days.
**Key Results:** A total of 15,422,986 sequences were processed, reduced to 4,022,717 after bioinformatics, with a mean of 33,804 sequences per sample (subsampled to 3,838). At the phylum level, the top five taxa were Proteobacteria (44%), Tenericutes (35%), Spirochaetota (11%), Desulfobacterota (6%), and Firmicutes (2%). At the genus level, Mycoplasma (35%), Brevinema (11%), Acinetobacter (10%), Aeromonas (6%), and Pseudomonas (5%) dominated. Alpha diversity was significantly affected by diet, time, and diet × time interaction (p < 0.01 for all indices). Fish infected with F. psychrophilum (Cb) had decreased alpha diversity and high Mycoplasma abundance. Florfenicol-treated fish (F) had increased alpha diversity compared to controls at day 24 p.i. Both antibiotic-treated groups showed increased abundance of potential pathogens: Acinetobacter, Pseudomonas (group F), and Aeromonas (group E). Mycoplasma disappeared after antibiotic treatment but reappeared by day 24. Beta diversity was significantly affected by diet and time (p < 0.001). Cumulative survival was 95% (group E), 91% (group F), and 90% (group Cb), with no significant differences between groups. Splenic F. psychrophilum was first detected on day 3 p.i. (1.61–1.80 log10 rpoC copies/reaction), with a significant increase in group F on day 12 p.i. compared to days 6 and 9.
**Clinical Implications:** Prophylactic oral treatment with florfenicol and erythromycin, as well as F. psychrophilum infection, significantly altered the intestinal microbiota composition of rainbow trout juveniles, with effects persisting at least 24 days post-infection. Both antibiotics reduced beneficial Mycoplasma and Brevinema while increasing potentially pathogenic genera (Aeromonas, Pseudomonas, Acinetobacter). The presence of Sphingomonas in florfenicol-treated fish suggests possible florfenicol degradation capacity. Neither antibiotic significantly improved survival against F. psychrophilum infection, though treated groups had numerically higher survival. These findings support cautious use of antibiotics in aquaculture and highlight the need for alternatives such as probiotics and prebiotics to preserve gut health and reduce antimicrobial resistance risks.